Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

Market Cap	4.50B -28.0%
Revenue (ttm)	3.35B -2.2%
Net Income	337.40M -9.5%
EPS	2.20 -10.5%
Shares Out	153.40M
PE Ratio	13.33
Forward PE	n/a
Dividend	0.90 (3.07%)
Ex-Dividend Date	Apr 28, 2026

Volume	5,834,400
Open	28.49
Previous Close	28.20
Day's Range	28.14 - 29.81
52-Week Range	24.68 - 43.72
Beta	0.18
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 20, 2026

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells traditional Chinese medicines and paediatric products in China. It provides over-the-counter, medical, and general health products in the form of capsules, granules, and gels under the Jianmin, Longmu, and Yekaitai brands. The company was founded in 1637 and is based in Wuhan, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1637
• Employees: 2,257
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600976

Financial Performance

In 2025, SHA:600976's revenue was 3.37 billion, a decrease of -3.85% compared to the previous year's 3.50 billion. Earnings were 359.84 million, a decrease of -0.65%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 3, 2026

Data Sources Report a data error